Quantitative Measurement of Disc Asymmetry in Glaucoma
Principal Investigator
Christopher Girkin, MD
University of Alabama at Birmingham
Birmingham, AL, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$50,000
Active Dates
April 01, 2000 - March 31, 2002
Grant ID
G2000007
Summary
Dr. Girkin hopes to determine whether a new technology for analyzing the optic nerve can be used to measure glaucomatous damage. This technology, known as confocal scanning laser ophthalmoscopy (CSLO), has the potential to allow for earlier diagnosis and to more accurately assess the progression of the disease. The quantitative aspect of currently used techniques is limited because of the normal variations in optic disc structure that occur even in a healthy population. However, structural differences between the two eyes in a healthy individual appear to be small, and Dr. Girkin is seeking to determine if measuring these differences with CSLO can be used to control for normal variability. In other words, he will determine the amount of asymmetry in optic disc structure in healthy individuals and determine if there is significantly greater asymmetry between the eyes of glaucoma patients or patients with high intraocular pressure. This is possible because even though glaucoma typically occurs in both eyes, it often progresses more quickly in one eye than in the other.
Related Grants
National Glaucoma Research
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
National Glaucoma Research
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
National Glaucoma Research
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute